scispace - formally typeset
F

Felix T. Wieland

Researcher at Heidelberg University

Publications -  158
Citations -  22192

Felix T. Wieland is an academic researcher from Heidelberg University. The author has contributed to research in topics: COPI & Golgi apparatus. The author has an hindex of 71, co-authored 158 publications receiving 20604 citations. Previous affiliations of Felix T. Wieland include Stanford University.

Papers
More filters
Journal ArticleDOI

Brefeldin A-induced increase of sphingomyelin synthesis. Assay for the action of the antibiotic in mammalian cells.

TL;DR: Using a radioactively labeled truncated ceramide this increase in sphingomyelin synthesis is easily detectable, and thus this method can serve as a convenient biochemical assay for the action of brefeldin A in mammalian cells.
Journal ArticleDOI

ArfGAP1 activity and COPI vesicle biogenesis.

TL;DR: It is found that catalytic amounts of Arf1GAP1 significantly reduce the yield of purified COPI vesicles and that Arf 1 rather than ArfGAP 1 constitutes a stoichiometric component of the COPI coat.
Journal ArticleDOI

Identification of novel sphingolipid-binding motifs in mammalian membrane proteins

TL;DR: The ability of the motif-containing candidate proteins to bind sphingolipids with high specificity opens new perspectives on their respective regulation and function.
Journal ArticleDOI

Induction of cortical endoplasmic reticulum by dimerization of a coatomer-binding peptide anchored to endoplasmic reticulum membranes.

TL;DR: It is suggested that Ist2 dimerization triggers coatomer binding and clustering of this protein into domains that traffic at the microtubule growing plus-end to generate the cER beneath the plasma membrane.
Journal ArticleDOI

Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ2 renders tumor cells dependent on its paralogous gene COPZ1

TL;DR: Silencing of microRNA 152 in different cancers and the ensuing down-regulation of its host gene COPZ2 offer a therapeutic opportunity for proliferation-independent selective killing of tumor cells by COPZ1-targeting agents.